Results 31 to 40 of about 3,980 (127)

Characteristics and Outcomes of Patients With Dedifferentiated Liposarcoma in a US Community Setting

Cancer Medicine, Volume 15, Issue 6, June 2026.
US community oncology patients with dedifferentiated liposarcoma have heterogeneous profiles, treatments, and outcomes. The poor survival rates in this population suggest an unmet need for better therapeutics. ABSTRACT Introduction Clinical characteristics and outcomes of patients treated for dedifferentiated liposarcoma (DDLPS) at community oncology ...
James E. Butrynski, Bal Nepal, Chenxiao Hu, Jinhong Guo, Jennifer Han, Lisa Herms, Alyssa B. Klein, Stephen Stanhope, Elizabeth L. Stanley, Karen Todoroff, Paul Conkling   +10 more
wiley   +1 more source

Kidney Sparing Huge Retroperitoneal Liposarcoma

Pakistan Journal of Medicine and Dentistry
Retroperitoneal Liposarcoma is a rare malignant tumor of mesenchymal origin and is the most common type of soft tissue sarcoma with a rate of 3-4 individuals for every million people.
Osama Kalim Shaikh, Mohammad Shoaib Mithani, Wajahat Fareed   +2 more
doaj   +1 more source

Dedifferentiated Retroperitoneal Liposarcoma Presenting as Right Inguinal Hernia: A Case Report

대한영상의학회지, 2016
Retroperitoneal liposarcomas usually present as painless, slow-growing abdominal masses. When masses grow large enough to compress surrounding structures, symptoms may occur. Retroperitoneal liposarcoma clinically manifesting as inguinal hernia is a very
Jung Myung Kim, Moon Hyung Choi, Su Lim Lee, Young Mi Ku   +3 more
doaj   +1 more source

Embryonal Paratesticular Rhabdomyosarcoma Masquerading as an Inguinal Hernia: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Embryonal paratesticular rhabdomyosarcoma can mimic benign inguinoscrotal conditions such as inguinal hernia. In children with persistent, painless scrotal masses, early cross‐sectional imaging and prompt radical inguinal orchiectomy with histopathological confirmation are essential.
Somaya Al Kiswani, Qusai Otoum, Morad Abbas, Momen Sawafta, Abdallateef salih, Omar Jaber, Azza Gharaibeh, Abdullah Nofal   +7 more
wiley   +1 more source

Contemporary Analysis of VTE Risk After HPB Surgery: 2517 Consecutive Patients Treated With Extended Chemoprophylaxis

World Journal of Surgery, Volume 50, Issue 6, Page 1663-1665, June 2026.
Independent predictors of Venous Thromboembolism (VTE) within the first 45 post‐operative days on multivariate analyses.
Anish J. Jain, Esther N. Dekker, Laura Prakash, Elsa M. Arvide, Yi‐Ju Chiang, Rebecca A. Snyder, Matthew H. G. Katz, Ching‐Wei D. Tzeng   +7 more
wiley   +1 more source

Neoadjuvant chemotherapy for soft‐tissue sarcoma of the extremities: A post‐hoc Sarculator‐based risk analysis of the EORTC 62961–ESHO 95 randomized trial

Cancer, Volume 132, Issue 9, 1 May 2026.
Abstract Background In the EORTC 62961–ESHO 95 randomized trial (European Organization for Research and Treatment 62961–European Society of Hyperthermia Oncology 95; ClinicalTrials.gov identifier NCT00003052), neoadjuvant chemotherapy (NAC) combined with regional hyperthermia (RHT) improved survival in patients with soft tissue sarcoma (tumor size >5 ...
Markus Albertsmeier, Valeria Milani, Lars H. Lindner, Gabriele Tinè, Sandro Pasquali, Dario Callegaro, Alessandro Gronchi, Hans‐Roland Dürr, Alexander Klein, Dorit Di Gioia, Sultan Abdel‐Rahman, Michael Schmidt, Jens Werner, Michael von Bergwelt‐Baildon, Rosalba Miceli, Rolf Issels   +15 more
wiley   +1 more source

Retroperitoneal dedifferentiated liposarcoma with colon infiltration: a case report and literature review

Frontiers in Oncology
Retroperitoneal dedifferentiated liposarcoma (RP DDLS) is considered highly malignant, with a high recurrence rate and poor prognosis, and is usually asymptomatic until the advanced stages.
Xi Tu, Xiyao Zhuang, Chaoyou Huang
doaj   +1 more source

RETROPERITONEAL NON-ORGAN LIPOSARCOMAS: THE MODERN CONCEPT

Сибирский онкологический журнал, 2019
Objective: to conduct a systematic literature review of the published studies on retroperitoneal non-organ liposarcomas.Material and Methods. A literature search was performed using Pubmed, Elibrary, COSMIC databases.
A. Yu. Volkov, S. N. Nered, L. N. Lyubchenko   +2 more
doaj   +1 more source

Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma

Clinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Retroperitoneal sarcoma cells can secrete prolactin into the bloodstream, inducing hyperprolactinaemia, which subsequently triggers metabolic reprogramming, such as glucose metabolism. SOX4 can function as a transcription factor that facilitates PRL transcription.
Fu'an Xie, Lingwei Gu, Kunrong Yang, Shuai Wang, Mengmeng Xiao, Guangting Yan, Quan Zhang, Rubing Liang, Aobo Zhuang, Zhe Xi, Yujia Niu, Yanhua Chen, Xiaogang Xia, Linlin Qu, Bin Zhao, Weibing Li, Ting Wu, Chundong Yu, Chenghua Luo, Houzhao Wang, Lanlan Lian, Wengang Li   +21 more
wiley   +1 more source

Intraoperative radiotherapy might not serve as a standard therapy for retroperitoneal liposarcoma: insights from a population-based propensity score-matched study

Frontiers in Oncology
BackgroundDifficulty in achieving complete resection leads to a poor prognosis for retroperitoneal soft tissue sarcoma, hence emphasizing the significance of adjuvant treatment. The benefit of preoperative radiotherapy for retroperitoneal liposarcoma was
Xiao Zhou, Xiao Zhou, Aobo Zhuang, Aobo Zhuang, Xi Li, Zhe Xi, Zhe Xi, Yingxue Cheng, Yingxue Cheng, Guangting Yan, Guangting Yan, Yue Wang, Yue Wang, Gen Zhang, Gen Zhang, Yangyang Huang, Chenhe Zhang, Chenhe Zhang, Fuan Xie, Fuan Xie, Xin Ma, Ting Wu, Wengang Li, Wengang Li   +23 more
doaj   +1 more source